Lowering Estimate for Cooper Industries

S&P revises earnings forecasts for Health Net and many others

Company: Brooks Automation (BRKS )

Year ending: Sep-02

Prior estimate: d0.52

New estimate: d0.96

Rationale: Company guidance

Company: Cooper Industries (CBE )

Year ending: Dec-02

Prior estimate: 3.64

New estimate: 3.05

Rationale: Margins suffer from economic weakness

Company: Health Net (HNT )

Year ending: Dec-02

Prior estimate: 1.85

New estimate: 2.08

Rationale: Nonamortization of goodwill

Company: Laboratory Corp. of America (LH )

Year ending: Dec-02

Prior estimate: 3.47

New estimate: 3.90

Rationale: Positive industry trends

Company: LaQuinta (LQI )

Year ending: Dec-02

Prior estimate: d0.57

New estimate: d3.15

Rationale: Higher restructuring charges

FEB. 22

Company: Aetna (AET )

Year ending: Dec-02

Prior estimate: 0.05

New estimate: 1.41

Rationale: Nonamortization of goodwill

Company: Andrx Group (ADRX )

Year ending: Dec-02

Prior estimate: 2.70

New estimate: 1.50

Rationale: Fourth quarter below expectations

Company: Barrick Gold (ABX )

Year ending: Dec-02

Prior estimate: 0.75

New estimate: 0.40

Rationale: Lower 2002 output, higher costs

Company: Bausch & Lomb (BOL )

Year ending: Dec-02

Prior estimate: 1.30

New estimate: 1.63

Rationale: Exclusion of goodwill amortization

Company: BEA Systems (BEAS )

Year ending: Jan-03

Prior estimate: 0.38

New estimate: 0.34

Rationale: Challenging economic environment

Company: Chesapeake Energy (CHK )

Year ending: Dec-02

Prior estimate: 0.77

New estimate: 0.51

Rationale: Updated prices, company guidance

Company: Circuit City (CC )

Year ending: Feb-03

Prior estimate: 1.18

New estimate: 0.60

Rationale: Planned CarMax spinoff

Company: Hispanic Broadcasting (HSP )

Year ending: Dec-02

Prior estimate: 0.34

New estimate: 0.38

Rationale: Improved outlook

Company: Medarex (MEDX )

Year ending: Dec-02

Prior estimate: d0.26

New estimate: d0.35

Rationale: Higher R&D

Company: VISX Inc. (EYE )

Year ending: Dec-02

Prior estimate: 0.60

New estimate: 0.45

Rationale: Slow eye correction volume

Company: Xilinx (XLNX )

Year ending: Mar-03

Prior estimate: 0.47

New estimate: 0.52

Rationale: Positive company update

Before it's here, it's on the Bloomberg Terminal. LEARN MORE